SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,420.47 |
| Enterprise Value ($M) | 1,997.74 |
| Book Value ($M) | 378.86 |
| Book Value / Share | 3.54 |
| Price / Book | 6.39 |
| NCAV ($M) | 377.55 |
| NCAV / Share | 3.53 |
| Price / NCAV | 6.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.52 |
| Return on Assets (ROA) | -0.57 |
| Return on Equity (ROE) | -0.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.61 |
| Current Ratio | 10.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 437.87 |
| Assets | 439.19 |
| Liabilities | 60.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Frazier Life Sciences X, L.P. | 15.30 | 29.96 | |
| 13D/A | Forbion Capital Fund IV Cooperatief U.A. | 10.40 | -5.90 | |
| 13D/A | BCLS II Investco, LP | 9.99 | 99.38 | |
| 13G/A | Ra Capital Management, L.p. | 9.99 | 10.96 | |
| 13G/A | Amgen Inc | |||
| 13G/A | Viking Global Investors Lp | 9.70 | 22.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 74,911 | 312,935 | 23.94 | |
| 300,699 | 1,441,065 | 20.87 | |
| 109,990 | 669,559 | 16.43 | |
| 103,282 | 308,729 | 33.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MRUS – Merus N.V. | MURA – Mural Oncology plc |
| NAII – Natural Alternatives International, Inc. | NEUP – Neuphoria Therapeutics Inc. |
| NGNE – Neurogene Inc. |
Financial data and stock pages provided by
Fintel.io